Angioimmunoblastic Lymphadenopathy with Dysproteinemia: Emphasis on Pathogenesis and Treatment

Publisher： Karger

E-ISSN： 1421-9662|99|2|57-64

ISSN： 0001-5792

Source： Acta Haematologica, Vol.99, Iss.2, 1998-03, pp. : 57-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Treatment of Angioimmunoblastic Lymphadenopathy with Dysproteinemia-Type T-Cell Lymphoma with Fludarabine

By  

Acta Haematologica, Vol. 105, Iss. 2, 2001-06 ,pp. : 106-108

Karger

Access to resources Recommend Favorite

Treatment of Angioimmunoblastic Lymphadenopathy with Dysproteinemia-Type T-Cell Lymphoma with Fludarabine

By  

Acta Haematologica, Vol. 109, Iss. 2, 2003-03 ,pp. : 110-

Karger

Access to resources Recommend Favorite

Angioimmunoblastic Lymphadenopathy: Treatment in Three Cases

By  

Acta Haematologica, Vol. 100, Iss. 3, 1998-12 ,pp. : 164-165

Karger

Access to resources Recommend Favorite

AN INQUIRY INTO THE PATHOGENESIS, RATIONAL TREATMENT AND PREVENTION OF MULTIPLE SCLEROSIS, WITH EMPHASIS UPON THE COMBINED ROLE OF DIABETOGENIC HYPER‐INSULINISM AND RECURRENT EDEMA*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 14, Iss. 6, 1966-06 ,pp. : 586-608

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Chemotherapy-Refractory Angioimmunoblastic T Cell Lymphoma with Cyclosporin A

By  

Acta Haematologica, Vol. 127, Iss. 1, 2011-10 ,pp. : 10-15

Karger

Access to resources Recommend Favorite